Update on nonserous ovarian cancer trials

Ann Oncol. 2013 Dec:24 Suppl 10:x46-x47. doi: 10.1093/annonc/mdt470.
No abstract available

Publication types

  • Review

MeSH terms

  • Adenocarcinoma, Mucinous / drug therapy*
  • Adenocarcinoma, Mucinous / pathology
  • Clinical Trials as Topic*
  • Female
  • Humans
  • Indoles / therapeutic use
  • Molecular Targeted Therapy
  • Ovarian Neoplasms / drug therapy*
  • Ovarian Neoplasms / pathology
  • TOR Serine-Threonine Kinases / antagonists & inhibitors*

Substances

  • Indoles
  • MTOR protein, human
  • TOR Serine-Threonine Kinases
  • nintedanib